| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC SODIUM | 1448 |
| 1 | ADALIMUMAB | 1428 |
| 2 | DICLOFENAC | 1428 |
| 3 | TOCILIZUMAB | 1381 |
| 4 | METHOTREXATE SODIUM | 1372 |
| 5 | ALENDRONATE SODIUM | 1368 |
| 6 | FOLIC ACID | 1349 |
| 7 | LEFLUNOMIDE | 1325 |
| 8 | RITUXIMAB | 1318 |
| 9 | METHOTREXATE | 1314 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRICLOSAN | 106 | 0.1985 |
| 1 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 99 | 0.1547 |
| 2 | CAFFEINE CITRATE | 301 | 0.1331 |
| 3 | NEOMYCIN OINTMENT | 307 | 0.1291 |
| 4 | DICLOFENAC POTASSIUM TABLETS | 977 | 0.1167 |
| 5 | HYDROCORTISONE BUTYRATE | 222 | 0.1162 |
| 6 | DICLOFENAC POTASSIUM | 977 | 0.0909 |
| 7 | CORTISONE ACETATE | 1016 | 0.0828 |
| 8 | CLEAR MINT, GEL TOOTHPASTE | 88 | 0.0825 |
| 9 | SODIUM FLUORIDE F18 | 88 | 0.0819 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1529 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1505 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 1458 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 1456 |
| 4 | Vitamin C [EPC] | 1421 |
| 5 | Vitamin B12 [EPC] | 1360 |
| 6 | Vitamin D [EPC] | 1353 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 1326 |
| 8 | Antirheumatic Agent [EPC] | 1325 |
| 9 | Aminosalicylate [EPC] | 1321 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 232 | 0.0226 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 296 | 0.0152 |
| 2 | Methylxanthine [EPC] | 745 | 0.0129 |
| 3 | Antirheumatic Agent [EPC] | 1325 | 0.0126 |
| 4 | Tetracycline-class Drug [EPC] | 869 | 0.0126 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 1458 | 0.0108 |
| 6 | Interleukin-12 Antagonist [EPC] | 1039 | 0.0102 |
| 7 | Aminosalicylate [EPC] | 1321 | 0.0100 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 791 | 0.0096 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 1171 | 0.0085 |